Market Size of Spirometers Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 602.70 Million |
Market Size (2029) | USD 803.89 Million |
CAGR (2024 - 2029) | 5.93 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Spirometers Market Analysis
The Spirometers Market size is estimated at USD 602.70 million in 2024, and is expected to reach USD 803.89 million by 2029, growing at a CAGR of 5.93% during the forecast period (2024-2029).
COVID-19 impacted the growth of the spirometer market owing to the decline in the diagnosis and treatment of patients suffering from respiratory diseases. For instance, according to the research study published in Elsevier Public Health Emergency, September 2021, it has been observed that the use of spirometry is restricted to immunocompromised patients for urgent treatment only, such as bone marrow transplants, lung transplants, and pre-chemotherapy treatments. Also, according to the research study published in PLOS One in February 2021, it has been observed that the risk for all-cause mortality is approximately two times higher in patients with COPD than in those without COPD, and a steep decline in visits to hospitals and clinics due to the lockdown measures imposed by the government has severely impacted the market growth during a pandemic. However, resumed diagnosis and treatment services for respiratory diseases and increased patient visits have increased market growth, are expected to regain their potential over the years, and may record healthy growth during the forecast period.
Factors such as the rise in the prevalence of chronic obstructive pulmonary disease (COPD), technological advancements in the field of spirometers, and a growing preference for home healthcare are boosting market growth.
The rising burden of COPD among the population raises the need for early detection of the COPD condition, which is expected to fuel the demand for spirometry tests. This is anticipated to augment market growth over the forecast period. For instance, as per an article published in the European Respiratory Journal, in November 2021, about 49,453,852 Europeans are expected to suffer from COPD by 2050, as compared to 36,580,965 in 2020. In addition, as per the same source, the Netherlands is expected to have the highest prevalence of COPD (14.6%) in Europe by 2050.
Additionally, according to the study published in PLOS ONE in January 2021, in France, there are currently 2.6 million people who have chronic obstructive pulmonary disease (COPD), and by 2025, that number is expected to rise to 2.8 million. Also, as per the 2022 statistics published by the NHS, about 1.17 million people in England were diagnosed with chronic obstructive pulmonary disorder (COPD) in 2020-2021, accounting for 1.9% of the total population. Thus, the expected increase in the number of people suffering from COPD is expected to increase the demand for technologically advanced spirometers, hence propelling market growth.
Furthermore, technological advances and the increasing portability and ease of operation of devices are anticipated to drive segment growth. For instance, in March 2021, Vyaire Medical launched the AioCare (HealthUp SA, Poland) mobile spirometry system in more than 15 countries, including Australia and other countries. This clinically proven technology expands upon Vyaire's deep respiratory diagnostics expertise and allows physicians to promptly diagnose pulmonary diseases including asthma and COPD as accurately as hospital-grade spirometers.
Moreover, the preference for home healthcare has increased among patients, which has increased the development of tele-spirometers or virtual spirometry tests, which is also contributing to the market's growth. For instance, in June 2021, eResearch Technology (ERT) launched ERT iSpiro Virtual Visits, which enables real-time coaching during at-home pulmonary function tests (PFT). iSpiro Virtual Visits makes it possible to gather high-quality spirometry data at home, keeping respiratory clinical studies on schedule, even when a patient is unable to visit a clinic.
Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. But not enough people know about chronic obstructive pulmonary disease (COPD), which is likely to slow the growth of the spirometer market over the next few years.
Spirometers Industry Segmentation
As per the scope of the report, a spirometer is a medical device that is used to measure the proper functioning of the lungs, where the volume of air inhaled and exhaled from the lungs is measured after maximum inhalation by the patient. A spirometer helps in the identification of different respiratory diseases, such as bronchitis, chronic lung diseases that are obstructive, emphysema, asthma, and other breathing diseases, for screening in an occupational environment. A spirometer is used to analyze lung function before surgery and predict respiratory diseases. The spirometers market is segmented by type (hand-held and table-top), technology (volume measurement and flow measurement), application (asthma, COPD, cystic fibrosis, and others), end-user (hospitals and clinics and home healthcare), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Type | |
Hand-Held | |
Table-Top |
By Technology | |
Volume Measurement | |
Flow Measurement |
By Application | |
Asthma | |
COPD | |
Cystic Fibrosis | |
Other Applications |
By End-User | |
Hospitals and Clinics | |
Home Healthcare |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Spirometers Market Size Summary
The spirometers market is poised for significant growth over the forecast period, driven by the increasing prevalence of chronic obstructive pulmonary disease (COPD) and advancements in spirometry technology. The market's expansion is supported by a rising demand for early detection of respiratory conditions, which is further fueled by the growing preference for home healthcare solutions. Technological innovations, such as portable and tele-spirometry devices, are enhancing the accessibility and convenience of spirometry tests, thereby boosting market adoption. The market's recovery from the COVID-19 pandemic, which had previously hindered growth due to reduced patient visits and diagnostic services, is expected to continue as healthcare services normalize and patient awareness increases.
North America is anticipated to experience robust growth in the spirometer market, attributed to the high incidence of respiratory diseases and a well-established healthcare infrastructure. The region's market growth is further supported by increased healthcare spending and the adoption of home health devices. The presence of major market players and ongoing product innovations are contributing to the competitive landscape, with companies like MGC Diagnostics Corporation and Koninklijke Philips N.V. playing pivotal roles. Collaborative efforts, such as partnerships and product launches, are enhancing the availability and functionality of spirometry devices, thereby driving market expansion. Despite the challenges posed by limited awareness of COPD, the market is expected to grow steadily, supported by the rising burden of respiratory conditions and technological advancements.
Spirometers Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rise in Prevalence of Chronic Obstructive Pulmonary Disease (COPD)
-
1.2.2 Technological Advancements in the Field Of Spirometers
-
1.2.3 Growing Preference for Home Healthcare
-
-
1.3 Market Restraints
-
1.3.1 Lack of Awareness regarding Chronic Obstructive Pulmonary Disease (COPD)
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Type
-
2.1.1 Hand-Held
-
2.1.2 Table-Top
-
-
2.2 By Technology
-
2.2.1 Volume Measurement
-
2.2.2 Flow Measurement
-
-
2.3 By Application
-
2.3.1 Asthma
-
2.3.2 COPD
-
2.3.3 Cystic Fibrosis
-
2.3.4 Other Applications
-
-
2.4 By End-User
-
2.4.1 Hospitals and Clinics
-
2.4.2 Home Healthcare
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia-Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia-Pacific
-
-
2.5.4 Middle East and Africa
-
2.5.4.1 GCC
-
2.5.4.2 South Africa
-
2.5.4.3 Rest of Middle East and Africa
-
-
2.5.5 South America
-
2.5.5.1 Brazil
-
2.5.5.2 Argentina
-
2.5.5.3 Rest of South America
-
-
-
Spirometers Market Size FAQs
How big is the Spirometers Market?
The Spirometers Market size is expected to reach USD 602.70 million in 2024 and grow at a CAGR of 5.93% to reach USD 803.89 million by 2029.
What is the current Spirometers Market size?
In 2024, the Spirometers Market size is expected to reach USD 602.70 million.